Table 2.
Placebo | Aspirin | P value | |
---|---|---|---|
n | 98 | 66 | NA |
Age | 22.4 ± 5.9 | 21.3 ± 4.8 | 0.3 |
Pre-pregnancy BMI | 28.0 ± 7.4 | 27.3 ± 5.9 | 0.9 |
Race White,non-Hispanic African American Hispanic |
26 (26.5) 52 (53.1) 20 (20.4) |
15 (22.7) 40 (60.6) 11 (16.7) |
0.6 |
Smoker at start of pregnancy | 24 (24.5) | 15 (22.7) | 0.8 |
Gestational age at delivery (weeks) | 38.6 ± 3.3 | 38.7 ± 4.1 | 0.1 |
Birth weight (grams) | 3197 ± 674 | 3240 ± 691 | 0.4 |
Systolic blood pressure (mmHg)** | 125 ± 8 | 122 ± 10 | 0.07 |
Diastolic blood pressure (mmHg)** | 75 ± 7 | 77 ± 7 | 0.2 |
Stage 1 hypertension= systolic blood pressure 130-135 mmHg or diastolic 80-85 mmHg;
Measured at enrollment (13-25 weeks of pregnancy); BMI= body mass index
Data are presented as mean ± standard deviation or n (%)